J
Jaguar Gene Therapy
Accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases
About Jaguar Gene Therapy
Jaguar Gene Therapy is a pioneering biotech startup that focuses on the development of gene therapies for severe genetic diseases. The company's primary mission is to accelerate breakthroughs in this field, aiming to provide hope and solutions for patients and families affected by these conditions.
Jaguar operates in the biotechnology and healthcare market, serving a client base that primarily consists of patients suffering from severe genetic diseases. The company's business model revolves around leveraging the expertise and manufacturing capabilities of its wholly-owned subsidiary, Advanced Medicine Partners. This partnership allows Jaguar to utilize a well-established gene therapy platform, designed to minimize development risk and deliver safe, effective therapies.
The company's revenue generation strategy is based on the development and commercialization of these gene therapies. By continuously evaluating next-generation technologies, including novel capsids and delivery methods, Jaguar aims to stay at the forefront of the industry, offering the most effective gene therapy products.
The company's success is driven by its team of experts in gene therapy, who have a proven track record in manufacturing, developing, and bringing gene therapies to patients. This expertise, combined with Jaguar's unrelenting commitment to its mission, positions the company as a strong contender in the gene therapy market.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| FundingOther financing | Mar 2022 | $0 | — | Samsung Ventures · JDRF T1D Fund | ↗ |
| SERIES BOther financing | Apr 2021 | $139M | $556M | ARCH Venture Partners · Deerfield · Eli Lilly · Goldman Sachs | — |
Growth signals
Latest recorded traffic for Jaguar Gene Therapy is 2.9K monthly website visits, up 3.6% over the last three months. Jaguar Gene Therapy's team grew 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Jaguar Gene Therapy in the Lake Forest ecosystem
The Jaguar Gene Therapy office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Deerfield
Eli Lilly
ARCH Venture Partners
Goldman Sachs
Nolan Capital
Other known investors2 additional known investors
JDRF T1D Fund
Samsung Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Jaguar Gene Therapy on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Jaguar Gene Therapy’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









